PMA device
Nucleus 24 Auditory Brainstem Implant
Cochlear Americas · Implant, Cochlear (MCM, Class III) · First FDA decision Aug 1, 2001, newest Apr 2, 2003Hearing loss
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
5
Naming "Nucleus 24 Auditory"
MAUDE reports
17
Brand "Nucleus 24 Auditory", since 2015
PubMed studies
0
Mentioning "Nucleus 24 Auditory"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Nucleus 24 Auditory Brainstem Implant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- NUCLEUS 24 AUDITORY BRAINSTEM IMPLANTPMA supplement
P000015-S004 · Decided Apr 2, 2003 · 117 days after receipt · Normal 180 Day Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
- NUCLEUS 24 AUDITORY BRAINSTEM IMPLANT SYSTEMPMA supplement
P000015-S003 · Decided Dec 9, 2002 · 39 days after receipt · Normal 180 Day Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
- NUCLEUS 24 AUDITORY BRAINSTEM IMPLANT SYSTEMPMA supplement
P000015-S002 · Decided Jan 7, 2002 · 168 days after receipt · Normal 180 Day Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cochlear ImplantationNational analysisReview closedCAG-00107RUpdated Sep 17, 2026
- Cochlear ImplantationNational analysisReview closedCAG-00107NUpdated Sep 17, 2026
- Cochlear ImplantationNational determinationOn the books50.3Updated Mar 26, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Nucleus 24 Auditory", any status and sponsor, newest update first.
Laurie EisenbergAcademic, hospital or other
NCT02102256 · 10 participants · Start Mar 2014 · Primary completion Apr 6, 2021
Device: Auditory Brainstem Implant · For: Profound Bilateral Deafness Due to; Bilateral Cochlear Aplasia; Bilateral Cochlear Nerve Deficiency and 1 more
Sites: Los Angeles, California · 2 sites in all
Massachusetts Eye and Ear InfirmaryAcademic, hospital or other
NCT01864291 · 9 participants · Start May 2013 · Primary completion Apr 25, 2019
Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI) · For: Bilateral Hearing Loss for Causes Other Than Tumors
Sites: Boston, Massachusetts
Massachusetts Eye and Ear InfirmaryAcademic, hospital or other
NCT01736267 · 3 participants · Start Nov 2012 · Primary completion Apr 25, 2019
Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI) · For: Bilateral Hearing Loss for Causes Other Than Tumors
Sites: Boston, Massachusetts
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Nucleus 24 Auditory", and for the whole product code for context.
This brand
17 reports: 6 malfunction, 11 injury, 0 death
Whole product code MCM
51,927 reports: 19,701 malfunction, 32,181 injury, 22 death
Newest reports for this brand
6000034-2016-02398 · Received Nov 30, 2016 · Event dated Oct 26, 2016
Device type: Implant, Auditory Brainstem (MHE)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: No Code Available
6000034-2016-02013 · Received Oct 11, 2016
Device type: Implant, Auditory Brainstem (MHE)
Device problem as coded: Migration or Expulsion of Device
Patient problem as coded: No Code Available
6000034-2016-01974 · Received Oct 10, 2016
Device type: Implant, Auditory Brainstem (MHE)
Device problem as coded: Migration or Expulsion of Device
Patient problem as coded: No Code Available
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Nucleus 24 Auditory"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MCM.
- HiResolution Bionic Ear SystemAdvanced Bionics · PMA 2026
- Nucleus® 24 Cochlear Implant SystemCochlear Americas · PMA 2025
- COMBI 40+ Cochlear Implant SystemMed-El Corp. · PMA 2019
- Nucleus Cochlear Implant SystemsCochlear Americas · PMA 2022
- Nucleus® 22 Cochlear Implant SystemCochlear Americas · PMA 2025
- MED-EL Cochlear ImplantMed-El Corp. · PMA 2026
- Harmony Hiresolution Bionic Ear SystemAdvanced Bionics · PMA 2012
- Clarion Multi-Strategy Cochlear ImplantAdvanced Bionics · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.